Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Natus buys hearing tech co SonaMed:

This article was originally published in Clinica

Executive Summary

Natus Medical is set to add to its hearing diagnostics portfolio with the acquisition of SonaMed, a specialist in newborn hearing screening. The cash transaction, of which the total sum was not disclosed, will see Natus gain Waltham, Massachusetts-based SonaMed's stand-alone Clarity Screener device and associated disposable supplies. The technology, used to test for hearing loss in newborns, helped SonaMed generate revenues of $3.5m in 2007. Natus (San Carlos, California) expects the deal to be accretive to earnings per share in the first full quarter of ownership. The transaction is expected to close during the second quarter of 2008.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT046771

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel